Post-Menopausal Women Do Well on HIV Therapy
Women living with HIV who’ve gone through menopause do just as well when starting antiretroviral (ARV) therapy for the first time, compared with pre-menopausal women, according to a study published online June 25 in Clinical Infectious Diseases.
July 01, 2009
Unexpected Finding: Penetration of ARVs Into Nervous System Doesn’t Protect the Brain While antiretroviral (ARV) drugs known to penetrate into the cerebrospinal fluid (CSF)—and thus possibly the brain—do lower HIV levels in the brain, they do not appear to protect against detrimental changes in thinking, memory and physical coordination. This is the conclusion of a study published in the July 17 issue of AIDS.
July 02, 2009
